Serum Institute of India (SII) enters into a new landmark partnership with Gavi, The Vaccine Alliance and the Bill & Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of #COVID19 vaccines for India and low & income countries: SII.
Vaccines will be priced at maximum USD 3 per dose & made available to up to 92 countries included in Gavi’s COVAX Advance Market Commitment… This collaboration underscores India’s proven-track record in developing safe and quality vaccines: Gavi, the Vaccine Alliance #COVID19.
